A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer

被引：0
|
作者：
Giampietro Gasparini
Francesco Torino
Takayuki Ueno
Stefano Cascinu
Teresa Troiani
Alberto Ballestrero
Rossana Berardi
Junichi Shishido
Akihiko Yoshizawa
Yukiko Mori
Satoshi Nagayama
Paola Morosini
Masakazu Toi
机构：
[1] Azienda Complesso Ospedaliero di Rilevanza Nazionale “S. Filippo Neri”,Unità Operativa Complessa di Oncologia Medica
[2] Kyoto University,Graduate School of Medicine
[3] Oncologia Medica Università delle Marche-Ospedale Umberto I,Department of Laboratory Medicine
[4] Oncologia Medica Università “Federico II”,undefined
[5] Dipartimento Medicina Interna Università di Genova,undefined
[6] Shinshu University Hospital,undefined
[7] Medical Affairs-Oncology,undefined
[8] Roche S.p.A.,undefined
来源：
Angiogenesis | 2012年 / 15卷
关键词：
Bevacizumab; Capecitabine; Radiotherapy; Rectal cancer; Neoadjuvant-treatment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：141 / 150
页数：9
相关论文
共 50 条
  • [1] A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer
    Gasparini, Giampietro
    Torino, Francesco
    Ueno, Takayuki
    Cascinu, Stefano
    Troiani, Teresa
    Ballestrero, Alberto
    Berardi, Rossana
    Shishido, Junichi
    Yoshizawa, Akihiko
    Mori, Yukiko
    Nagayama, Satoshi
    Morosini, Paola
    Toi, Masakazu
    [J]. ANGIOGENESIS, 2012, 15 (01) : 141 - 150
  • [2] PHASE II TRIAL OF NEOADJUVANT BEVACIZUMAB, CAPECITABINE, AND RADIOTHERAPY FOR LOCALLY ADVANCED RECTAL CANCER
    Crane, Christopher H.
    Eng, Cathy
    Feig, Barry W.
    Das, Prajnan
    Skibber, John M.
    Chang, George J.
    Wolff, Robert A.
    Krishnan, Sunil
    Hamilton, Stanley
    Janjan, Nora A.
    Maru, Dipen M.
    Ellis, Lee M.
    Rodriguez-Bigas, Miguel A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 76 (03): : 824 - 830
  • [3] Neoadjuvant Radiochemotherapy with Capecitabine and Oxaliplatin plus bevacizumab in locally advanced Rectal Cancer - Results of a phase II study
    Dellas, K.
    Hoehler, T.
    Riesenbeck, D.
    Reese, T.
    Wuerschtnidt, F.
    Engel, E.
    Roedel, C.
    Wagner, W.
    Richter, M.
    Dunst, J.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 : 51 - 51
  • [4] Neoadjuvant Radiotherapy with Capecitabine Plus Bevacizumab for Locally Advanced Lower Rectal Cancer: Results of a Single-institute Phase II Study
    Maeda, Kiyoshi
    Shibutani, Masatsune
    Otani, Hiroshi
    Fukuoka, Tatsunari
    Iseki, Yasuhito
    Matsutani, Shinji
    Nagahara, Hisashi
    Inoue, Toru
    Tachimori, Akiko
    Nishii, Takafumi
    Miki, Yoshitaka
    Hosono, Masako
    Ohira, Masaichi
    [J]. ANTICANCER RESEARCH, 2018, 38 (07) : 4193 - 4197
  • [5] Phase II study of capecitabine (Xeloda®) and concomitant boost radiotherapy in patients with locally advanced rectal cancer
    Krishnan, Sunil
    Janjan, Nora A.
    Skibber, John M.
    Rodriguez-Bigas, Miguel A.
    Wolff, Robert A.
    Das, Prajnan
    Delclos, Marc E.
    Chang, George J.
    Hoff, Paulo M.
    Eng, Cathy
    Brown, Thomas D.
    Crane, Christopher H.
    Feig, Barry W.
    Morris, Jeffrey
    Vadhan-Raj, Saroj
    Hamilton, Stanley R.
    Lin, Edward H.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : 762 - 771
  • [6] Phase II study of capecitabine and radiotherapy (RT) plus concomitant boost in patients (pts) with locally advanced rectal cancer (LARC).
    Shi, GG
    Lin, E
    Eng, C
    Delcos, M
    Crane, C
    Amos, CB
    Brown, T
    Abbruzzese, JL
    Skibber, J
    Janjan, N
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 312S - 312S
  • [7] Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single-institute phase II study
    Yu, Xin
    Wang, Qiao-xuan
    Xiao, Wei-wei
    Chang, Hui
    Zeng, Zhi-fan
    Lu, Zhen-hai
    Wu, Xiao-jun
    Chen, Gong
    Pan, Zhi-zhong
    Wan, De-sen
    Ding, Pei-rong
    Gao, Yuan-hong
    [J]. CANCER COMMUNICATIONS, 2018, 38
  • [8] Phase II study of preoperative bevacizumab, capecitabine, and radiotherapy for resectable locally advanced rectal cancer
    Martinez Villacampa, M.
    Santos, C.
    Garcia, M.
    Navarro, V.
    Teule, A.
    Losa, F.
    Pisa, A.
    Lema, L.
    Biondo, S.
    Salazar, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [9] Phase II trial of neoadjuvant bevacizumab (BEV), capecitabine (CAP), and radiotherapy (XRT) for locally advanced rectal cancer
    Crane, C. H.
    Eng, C.
    Feig, B. W.
    Das, P.
    Skibber, J. M.
    Chang, G. J.
    Wolff, R. A.
    Krishnan, S.
    Maru, D. M.
    Ellis, L. M.
    Rodriguez-Bigas, M. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study
    Velenik, Vaneja
    Ocvirk, Janja
    Music, Maja
    Bracko, Matej
    Anderluh, Franc
    Oblak, Irena
    Edhemovic, Ibrahim
    Brecelj, Erik
    Kropivnik, Mateja
    Omejc, Mirko
    [J]. RADIATION ONCOLOGY, 2011, 6
12345